1-20 of 32
Walter J. Storkus
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 3966: NK receptors enable TCR-mediated CTL recognition and killing of cancer cells expressing non-mutated tumor-associated antigens

Free
Bowen Dong, Nataša Obermajer, Takemasa Tsuji, Junko Matsuzaki, Cindy Bonura, Henry Withers, Mark Long, Colin Chavel, Scott H. Olejniczak, Hans Minderman, Robert P. Edwards, Walter J. Storkus, Pedro Romero, Pawel Kalinski
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 3966.
https://doi.org/10.1158/1538-7445.AM2024-3966
Published: 22 March 2024
View articletitled, Abstract 3966: NK receptors enable TCR-mediated CTL recognition and killing of cancer cells expressing non-mutated tumor-associated antigens
Journal Articles

Abstract 4655: The prognostic significance of a 12-chemokine tertiary lymphoid structure (TLS) gene signature in uveal melanoma (UM)

Free
Hassan Mohammed Abushukair, Ayah Al-Bzour, Andrew Knight, Walter J. Storkus, John M. Kirkwood, Lilit Karapetyan
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 4655.
https://doi.org/10.1158/1538-7445.AM2023-4655
Published: 04 April 2023
View articletitled, Abstract 4655: The prognostic significance of a 12-chemokine tertiary lymphoid structure (TLS) gene signature in uveal melanoma (UM)
Journal Articles

Abstract 5169: Sentinel lymph node gene expression signature predicts survival outcome in cutaneous melanoma

Free
Lilit Karapetyan, William Gooding, Xi Yang, Andrew Knight, Aofei Li, Cindy Sander, Monica Panelli, Walter J. Storkus, Ahmad A. Tarhini, John M. Kirkwood
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 5169.
https://doi.org/10.1158/1538-7445.AM2022-5169
Published: 15 June 2022
View articletitled, Abstract 5169: Sentinel lymph node gene expression signature predicts survival outcome in cutaneous melanoma
Journal Articles

Abstract 2683: Serum multiplex analysis of tertiary lymphoid structure-associated chemokines/cytokines in melanoma patients

Free
Lilit Karapetyan, Xi Yang, Hong Wang, Cindy Sander, Arivarasan Karunamurthy, John M. Kirkwood, Walter J. Storkus
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 2683.
https://doi.org/10.1158/1538-7445.AM2021-2683
Published: 01 July 2021
View articletitled, Abstract 2683: Serum multiplex analysis of tertiary lymphoid structure-associated chemokines/cytokines in melanoma patients
Journal Articles

Abstract 1748: Head and neck cancer-derived exosomes facilitate carcinogenesis in the murine 4NQO chemically induced oropharyngeal cancer

Free
Beatrice M. Razzo, Chang-Sook Hong, Kellsye P. Fabian, Nils Ludwig, Priyanka Sharma, Walter J. Storkus, Theresa L. Whiteside
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 1748.
https://doi.org/10.1158/1538-7445.AM2018-1748
Published: 01 July 2018
View articletitled, Abstract 1748: Head and neck cancer-derived exosomes facilitate carcinogenesis in the murine 4NQO chemically induced oropharyngeal cancer
Journal Articles

Abstract LB-225: Combination immunotherapy targeting HSP90 DNA-repair client proteins overexpressed in chemotherapy-resistant melanoma

Free
Subhara Raveendran, Ronald Fecek, Cara Donahue Carey, Walter J. Storkus
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): LB-225.
https://doi.org/10.1158/1538-7445.AM2016-LB-225
Published: 15 July 2016
View articletitled, Abstract LB-225: Combination immunotherapy targeting HSP90 DNA-repair client proteins overexpressed in chemotherapy-resistant melanoma
Journal Articles

Combination Therapy with HSP90 Inhibitor 17-DMAG Reconditions the Tumor Microenvironment to Improve Recruitment of Therapeutic T cells

Free
Aparna Rao, Jennifer L. Taylor, Nina Chi-Sabins, Mayumi Kawabe, William E. Gooding, Walter J. Storkus
Journal: Cancer Research
Cancer Res (2012) 72 (13): 3196–3206.
https://doi.org/10.1158/0008-5472.CAN-12-0538
Published: 01 July 2012
View articletitled, Combination Therapy with HSP90 Inhibitor 17-DMAG Reconditions the Tumor Microenvironment to Improve Recruitment of Therapeutic T cells
Open the PDF for Combination Therapy with HSP90 Inhibitor 17-DMAG Reconditions the Tumor Microenvironment to Improve Recruitment of Therapeutic T cells in another window
Includes: Supplementary data
Journal Articles

Abstract 1537: Combined Tbet and IL-12 gene therapy elicits and recruits superior anti-tumor immunity in vivo

Free
Jennifer L. Taylor, Yanyan Qu, Lu Chen, Devin B. Lowe, Walter J. Storkus
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 1537.
https://doi.org/10.1158/1538-7445.AM2012-1537
Published: 15 April 2012
View articletitled, Abstract 1537: Combined Tbet and IL-12 gene therapy elicits and recruits superior anti-tumor immunity in vivo
Journal Articles

Abstract 4399: Immunostimulatory effects of HSP90 inhibition: Insights from combinational immunotherapies targeting EphA2

Free
Aparna Rao, Mayumi Kawabe, Walter J. Storkus
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 4399.
https://doi.org/10.1158/1538-7445.AM2012-4399
Published: 15 April 2012
View articletitled, Abstract 4399: Immunostimulatory effects of HSP90 inhibition: Insights from combinational immunotherapies targeting EphA2
Journal Articles

Abstract 1805: Integration of 17-(Dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG) in combinational immunotherapy targeting tumor antigen EphA2

Free
Aparna Rao, Mayumi Kawabe, Walter J. Storkus
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 1805.
https://doi.org/10.1158/1538-7445.AM2011-1805
Published: 15 April 2011
View articletitled, Abstract 1805: Integration of 17-(Dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG) in combinational immunotherapy targeting tumor antigen EphA2
Journal Articles

A Therapeutic OX40 Agonist Dynamically Alters Dendritic, Endothelial, and T Cell Subsets within the Established Tumor Microenvironment

Free
Angela D. Pardee, Dustin McCurry, Sean Alber, Peisheng Hu, Alan L. Epstein, Walter J. Storkus
Journal: Cancer Research
Cancer Res (2010) 70 (22): 9041–9052.
https://doi.org/10.1158/0008-5472.CAN-10-1369
Published: 14 November 2010
View articletitled, A Therapeutic OX40 Agonist Dynamically Alters Dendritic, Endothelial, and T Cell Subsets within the Established Tumor Microenvironment
Open the PDF for A Therapeutic OX40 Agonist Dynamically Alters Dendritic, Endothelial, and T Cell Subsets within the Established Tumor Microenvironment in another window
Includes: Supplementary data
Journal Articles

Abstract 3824: Induction of potent antitumor immunity by intratumoral injection of mT-bet transduced dendritic cells

Free
Yanyan Qu, Michael W. Lipscomb, Jennifer L. Taylor, Walter J. Storkus
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 3824.
https://doi.org/10.1158/1538-7445.AM10-3824
Published: 15 April 2010
View articletitled, Abstract 3824: Induction of potent antitumor immunity by intratumoral injection of mT-bet transduced dendritic cells
Journal Articles

Abstract 2938: A novel OX40 agonist licenses systemic anti-tumor immunity to overcome local immune suppression induced by well-established tumors

Free
Angela D. Pardee, Alan L. Epstein, Walter J. Storkus
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 2938.
https://doi.org/10.1158/1538-7445.AM10-2938
Published: 15 April 2010
View articletitled, Abstract 2938: A novel OX40 agonist licenses systemic anti-tumor immunity to overcome local immune suppression induced by well-established tumors
Journal Articles

Heat Shock Protein 90 Inhibitor 17-Dimethylaminoethylamino-17-Demethoxygeldanamycin Enhances EphA2+ Tumor Cell Recognition by Specific CD8+ T Cells

Free
Mayumi Kawabe, Maja Mandic, Jennifer L. Taylor, Cecilia A. Vasquez, Amy K. Wesa, Leonard M. Neckers, Walter J. Storkus
Journal: Cancer Research
Cancer Res (2009) 69 (17): 6995–7003.
https://doi.org/10.1158/0008-5472.CAN-08-4511
Published: 31 August 2009
View articletitled, Heat Shock Protein 90 Inhibitor 17-Dimethylaminoethylamino-17-Demethoxygeldanamycin Enhances EphA2+ Tumor Cell Recognition by Specific CD8+ T Cells
Open the PDF for Heat Shock Protein 90 Inhibitor 17-Dimethylaminoethylamino-17-Demethoxygeldanamycin Enhances EphA2+ Tumor Cell Recognition by Specific CD8+ T Cells in another window
Includes: Supplementary data
Journal Articles

CD8+ T-Cell Responses against Hemoglobin-β Prevent Solid Tumor Growth

Free
Hideo Komita, Xi Zhao, Jennifer L. Taylor, Louis J. Sparvero, Andrew A. Amoscato, Sean Alber, Simon C. Watkins, Angela D. Pardee, Amy K. Wesa, Walter J. Storkus
Journal: Cancer Research
Cancer Res (2008) 68 (19): 8076–8084.
https://doi.org/10.1158/0008-5472.CAN-08-0387
Published: 30 September 2008
View articletitled, CD8+ T-Cell Responses against Hemoglobin-β Prevent Solid Tumor Growth
Open the PDF for CD8+ T-Cell Responses against Hemoglobin-β Prevent Solid Tumor Growth in another window
Includes: Supplementary data
Journal Articles

Helper Function of Memory CD8+ T Cells: Heterologous CD8+ T Cells Support the Induction of Therapeutic Cancer Immunity

Free
Yutaro Nakamura, Payal Watchmaker, Julie Urban, Brian Sheridan, Adam Giermasz, Fumihiko Nishimura, Kotaro Sasaki, Rachel Cumberland, Ravikumar Muthuswamy, Robbie B. Mailliard, Adriana T. Larregina, Louis D. Falo, William Gooding, Walter J. Storkus, Hideho Okada, Robert L. Hendricks, Pawel Kalinski
Journal: Cancer Research
Cancer Res (2007) 67 (20): 10012–10018.
https://doi.org/10.1158/0008-5472.CAN-07-1735
Published: 17 October 2007
View articletitled, Helper Function of Memory CD8+ T Cells: Heterologous CD8+ T Cells Support the Induction of Therapeutic Cancer Immunity
Open the PDF for Helper Function of Memory CD8+ T Cells: Heterologous CD8+ T Cells Support the Induction of Therapeutic Cancer Immunity in another window
Journal Articles

Preferential Expression of Very Late Antigen-4 on Type 1 CTL Cells Plays a Critical Role in Trafficking into Central Nervous System Tumors

Free
Kotaro Sasaki, Xinmei Zhu, Cecilia Vasquez, Fumihiko Nishimura, Jill E. Dusak, Jian Huang, Mitsugu Fujita, Amy Wesa, Douglas M. Potter, Paul R. Walker, Walter J. Storkus, Hideho Okada
Journal: Cancer Research
Cancer Res (2007) 67 (13): 6451–6458.
https://doi.org/10.1158/0008-5472.CAN-06-3280
Published: 06 July 2007
View articletitled, Preferential Expression of Very Late Antigen-4 on Type 1 CTL Cells Plays a Critical Role in Trafficking into Central Nervous System Tumors
Open the PDF for Preferential Expression of Very Late Antigen-4 on Type 1 CTL Cells Plays a Critical Role in Trafficking into Central Nervous System Tumors in another window
Includes: Supplementary data
Journal Articles

Identification of Interleukin-13 Receptor α2 Peptide Analogues Capable of Inducing Improved Antiglioma CTL Responses

Free
Junichi Eguchi, Manabu Hatano, Fumihiko Nishimura, Xinmei Zhu, Jill E. Dusak, Hidemitsu Sato, Ian F. Pollack, Walter J. Storkus, Hideho Okada
Journal: Cancer Research
Cancer Res (2006) 66 (11): 5883–5891.
https://doi.org/10.1158/0008-5472.CAN-06-0363
Published: 01 June 2006
View articletitled, Identification of Interleukin-13 Receptor α2 Peptide Analogues Capable of Inducing Improved Antiglioma CTL Responses
Open the PDF for Identification of Interleukin-13 Receptor α2 Peptide Analogues Capable of Inducing Improved Antiglioma CTL Responses in another window
Journal Articles

Combinational FLt3 Ligand and Granulocyte Macrophage Colony-Stimulating Factor Treatment Promotes Enhanced Tumor Infiltration by Dendritic Cells and Antitumor CD8+ T-Cell Cross-priming but Is Ineffective as a Therapy

Free
Aklile Berhanu, Jian Huang, Sean M. Alber, Simon C. Watkins, Walter J. Storkus
Journal: Cancer Research
Cancer Res (2006) 66 (9): 4895–4903.
https://doi.org/10.1158/0008-5472.CAN-05-2384
Published: 01 May 2006
View articletitled, Combinational FLt3 Ligand and Granulocyte Macrophage Colony-Stimulating Factor Treatment Promotes Enhanced Tumor Infiltration by Dendritic Cells and Antitumor CD8+ T-Cell Cross-priming but Is Ineffective as a Therapy
Open the PDF for Combinational FLt3 Ligand and Granulocyte Macrophage Colony-Stimulating Factor Treatment Promotes Enhanced Tumor Infiltration by Dendritic Cells and Antitumor CD8+ T-Cell Cross-priming but Is Ineffective as a Therapy in another window
Journal Articles

Adoptive Transfer of Type 1 CTL Mediates Effective Anti–Central Nervous System Tumor Response: Critical Roles of IFN-Inducible Protein-10

Free
Fumihiko Nishimura, Jill E. Dusak, Junichi Eguchi, Xinmei Zhu, Andrea Gambotto, Walter J. Storkus, Hideho Okada
Journal: Cancer Research
Cancer Res (2006) 66 (8): 4478–4487.
https://doi.org/10.1158/0008-5472.CAN-05-3825
Published: 17 April 2006
View articletitled, Adoptive Transfer of Type 1 CTL Mediates Effective Anti–Central Nervous System Tumor Response: Critical Roles of IFN-Inducible Protein-10
Open the PDF for Adoptive Transfer of Type 1 CTL Mediates Effective Anti–Central Nervous System Tumor Response: Critical Roles of IFN-Inducible Protein-10 in another window
Includes: Supplementary data